A full house at 1st SingHealth Sarcoma and Skin Symposium at the National Cancer Centre Singapore, 19-20 July 2023. Wonderful to see so many people from all walks of life dedicated towards improving outcomes for our patients with #Sarcoma or #Skin Cancers! #rarecancer
🌟"ATLAS Monthly Webinar" series🌟
We are excited to announce the ATLAS Monthly Webinar!
This seminar series aims to share the latest advancements in cancer research, and treatment.
We look forward to your participation😊
Date: 2026/01/28
Registration: https://t.co/JTjPhCnSno
🌟ATLAS Monthly Webinar🌟
Speaker Introduction
Dr. Valerie Yang
National Cancer Centre Singapore
Title: Combating Soft Tissue Sarcomas: Strategies for Impact
Date: March 27th, 2025
Registration: https://t.co/xjtnpYVBSO
🌟"ATLAS Monthly Webinar" series🌟
We are excited to announce the ATLAS Monthly Webinar! This seminar series aims to share the latest advancements in cancer research, and treatment. We look forward to your participation😊
Date: 2025/03/27
Registration: https://t.co/xjtnpYW9Im
‼️Coming up 🔜 @ctosociety Webinar on “Dedifferentiated Liposarcoma”- the 2024 #sarcoma of the year! Please join us for an in-depth overview of the state-of-the-art of DDLPS diagnostics, biology, and clinical management on October 10!
Register here👇
https://t.co/calRPfl1iA
@careforhana@oncodaily Yes I absolutely agree. A massive challenge to put fragmented data together, what more in rare cancers. What applies to Asia also differs from MENA - biology aside, access, reimbursement and healthcare logistics also make a huge difference.
No. HaNSA isn't the name of a Korean girl band🤣 It's the Head and Neck Sarcoma Assessor! This helps guide clinicians managing these rare cancers make treatment decisions. Scan the QR code to try this out for yourself!
https://t.co/KLuMU92oLs
#sarcoma#rarecancer#CTOSTweetos
Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors.
https://t.co/URro4jvpTL
Dr. Christopher Fletcher made an incredible impact on sarcoma research and the sarcoma community. We are deeply saddened by his passing and are immensely grateful for his remarkable contributions.
Pictured here at the #SARCtrials Semi-Annual Meeting at #CTOS this past November, Dr. Chris Fletcher has had an astounding impact on #sarcoma research and the sarcoma community. We are saddened to learn of his passing and are grateful for his amazing contributions.